Abstract:Objective To evaluate the efficacy and safety of intravitreal injection of Bevacizumab (Avastin) combined with laser photocoagulation in the patients of macular edema secondary to retinal vein occlusion (RVO).Methods This was a retrospective cases-series study.Thirty eyes of 30 RVO patients (branch RVO 20 eyes and central RVO 10 eyes) were erolled,aged from 34 to 79,with average of (57.3±8.9)years.The eyes were treated with intravitreal injections of Bevacizumab (1.25 mg) combined with laser photocoagulation.The treatment method of intravitreal injection had been conducted according to PrONTO study.Best corrected visual acuity (BCVA,ETDRS letters),fundus photography,optical coherence tomography (OCT) were committed at baseline and 1,3,6,12 months after intravitreal injection.The ETDRS letters and the central retinal thickness (CRT) by OCT were recorded.Changes in BCVA and CRT measurements from baseline at the various follow-up endpoints were assessed with paired t test.Spearman correlation coefficient was used to measure the strength of correlation between BCVA and anatomic changes.Results The mean number of the injections in the 30 patients was 3.9±1.9.The BCVA improved 3 or more lines in 16 eyes (54％),improved 1 to 2 lines in 10 eyes (33％),stabilized (±1 line or no change) in 4 eyes (13％) and none decreased.The average BCVA at baseline was (42±19) letters,and improved to (60±19) letters at 12 months (t=7.87,P＜0.05).The average of retinal thickness of macular foveal decreased from (616.7±177.0)μm at baseline to (268.9±l15.9)μm at 12 months (t=13.23,P＜0.05).BCVA 12 months post-treatment was correlated to BCVA pre-treatment (r=0.791,P＜0.01).Macular edema had no correlation with baseline and finally BCVA.21 eyes (70％) showed no observed macular edema by the last follow-up and the side effects were not observed during the follow-up.Conclusion The persistent and rebound macular edema found in Bevacizumab treatment had some common characteristics in FFA. Combined intravitreal injections of Bevacizumab and laser photocoagulation therapy seemed to be effective for managing some refractory macular edema secondary to RVO.The Bevacizumab and photocoagulation related adverse events are rare.

The clinical study onintravitreous injection of avastin for macular edema induced by branch retinal veinocclusion

The clinical study on intravitreous injection of avastin for macular edema induced by branch retinal vein occlusion

Clinical study on intravitreous injection of Avastin for macular edema induced by central retinal vein occlusion

Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

Macular Edema Patterns and Response to Intravitreal Avastin Therapy in Branch Retinal Vein Occlusion

Effect of intravitreal injection of Avastin combined with triamicinolone acetonide for treatment of branch retinal vein occlusion and crystal macular edema

Intravitreous bevacizumab(Avastin) therapy for diffuse diabetic macular edema

Clinical Observation of Intravitreal Bevacizumab Combined with Laser Photocoagulation for Treatment of Macular Edema Secondary to Retinal Vein Occlusion

Short-term efficacy of introvitreal injection of Avastin for acute central serous chorioretinopathy

Intravitreal Bevacizumab Treatment for Branch Retinal Vein Occlusion Accompanied by Macular Edema

Intravitreal Triamcinolone Versus Bevacizumab for the Treatment of Macular Edema in Retinal Vein Occlusion

The Safety, Effectiveness and Prognostic Factors of Intravitreal Avastin (Bevacizumab) Injection for the Treatment of Macular Edema at the University of Gondar Tertiary Eye Care and Training Center, NW Ethiopia

Observation on Intravitreal Injection of Ranibizumab Combined with Laser Photocoagulation for the Treatment of Macular Edema in BRVO

Intravitreal triamcinolone acetinide vs bevacizumab for macular edema due to non-ischaemic central retinal vein occlusion

Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage.

Intravitreal Bevacizumab Versus Triamcinolone Acetonide for Macular Edema Due to Branch Retinal Vein Occlusion: a Matched Study.

Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects

Comparison of intravitreal injection of conbercept and macular photocoagulation for non-ischemic macular edema secondary to branch retinal vein occlusion

Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.

Clinical Observation of Intravitreal Injection of Triamcinolone Acetonide for Macular Edema Secondary to Retinal Vein Occlusion

Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis